ACTIDOM DA

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
ACTIDOM DA
Generic name
CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE
Manufacturer
ACTIPHARMA, LLC
Product type
HUMAN OTC DRUG
SPL set ID
7797c22e-ffeb-4798-9fb6-aa64cf077ba7
SPL ID
e2d0fae5-74da-4a40-8e64-708a3d237ea8
Version
2
Effective date
2024-07-15
Source export date
2026-09-28
Source partition
1
Source file
https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/9c7783846d422acb0c9e59457606951c785a7d28cc631c8cc4839d0dc7c55f39/drug-label-0001-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:12:44
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

​Warnings Do not use in a child who is taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your child's prescription drug contains an MAOI, ask a doctor or pharmacist before giving this product. Ask a doctor before use if child has • heart disease • diabetes • high blood pressure • thyroid disease • glaucoma • a breathing problem such as chronic bronchitis Do not give this product to children who are taking sedatives or tranquilizers, without first consulting the child's doctor. When using this product • do not exceed recommended dosage • may cause excitability especially in children • may cause drowsiness • sedatives and tranquilizers may increase the drowsiness effect Stop use and ask a doctor if • nervousness, dizziness, or sleeplessness occur • symptoms do not improve within 7 days or are accompanied by fever. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.